| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM198010093031502 |
| P698 | PubMed publication ID | 7412801 |
| P2093 | author name string | Sasahara AA | |
| Sharma GV | |||
| Burleson VA | |||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thrombolysis | Q1931577 |
| P304 | page(s) | 842-845 | |
| P577 | publication date | 1980-10-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Effect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism | |
| P478 | volume | 303 |
| Q69783648 | Acute and chronic pulmonary thromboembolism: current perspectives. Part VIII: Summary and references |
| Q39607069 | Acute pulmonary embolism treated with thrombolytic agents: current status of tPA and future implications for emergency medicine |
| Q69887713 | Acute pulmonary embolism treated with tissue plasminogen activator |
| Q33606169 | Antithrombotic therapy for pulmonary embolism. |
| Q35383966 | Approach to the patient with venous thromboembolism. Treatment with thrombolytic agents |
| Q40618236 | Chemokines Accumulate in the Lungs of Rats with Severe Pulmonary Embolism Induced by Polystyrene Microspheres |
| Q74485252 | Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up |
| Q39602689 | Deep vein thrombosis and pulmonary embolism: clinical presentation and pathophysiologic consequences |
| Q40746384 | Deep vein thrombosis. Diagnosis and management. |
| Q36148617 | Difficulties in the treatment of acute pulmonary embolism |
| Q33159285 | Fibrinolysis for acute pulmonary embolism |
| Q39602682 | Fibrinolytic therapy for deep vein thrombosis and pulmonary embolism |
| Q28071396 | Guidance for the use of thrombolytic therapy for the treatment of venous thromboembolism |
| Q49359633 | How I use catheter-directed interventional therapy to treat patients with venous thromboembolism |
| Q35640900 | Indications for thrombolytic therapy in acute pulmonary embolism |
| Q35104332 | Local and systemic thrombolytic therapy for acute venous thromboembolism |
| Q34306094 | Looking forward in the treatment of deep-vein thrombosis |
| Q54991512 | Management of patients with high-risk pulmonary embolism: a narrative review. |
| Q34227288 | Management of venous thromboembolic disease in the chronically critically ill patient |
| Q69444784 | Measurement of diffusing capacity in pulmonary embolism |
| Q89908092 | Mechanisms of hypoxemia |
| Q39627556 | New drug therapy in peripheral vascular disease. |
| Q34111010 | Physical medicine and rehabilitation-epitomes of progress: thrombolytic therapy for deep venous thrombosis and pulmonary embolism. |
| Q33496843 | Prevention and treatment of venous thromboembolism |
| Q39749124 | Preventive and therapeutic approach to venous thromboembolic disease and pulmonary embolism--can death from pulmonary embolism be prevented? |
| Q70804723 | Pulmonary embolism |
| Q69521544 | Pulmonary embolism |
| Q36680601 | Pulmonary embolism--the role of thrombolytic therapy in its management |
| Q69955983 | Pulmonary hypertension |
| Q39629785 | Recent advances in the management of venous thromboembolism. |
| Q35064691 | Reduction in membrane component of diffusing capacity is associated with the extent of acute pulmonary embolism |
| Q34111166 | Risk of complications during intravenous heparin therapy |
| Q53546266 | Successful treatment of massive pulmonary embolism with prolonged catheter-directed thrombolysis. |
| Q35115224 | Systematic review and meta-analysis for thrombolysis treatment in patients with acute submassive pulmonary embolism |
| Q40076028 | The fibrinolytic system in man |
| Q37275338 | The use of thrombolytic therapy in pregnancy |
| Q71328224 | Therapeutic approach to acute pulmonary embolism |
| Q37663115 | Thrombolytic therapy for noncoronary diseases |
| Q90603182 | Thrombolytic therapy for pulmonary embolism |
| Q24186934 | Thrombolytic therapy for pulmonary embolism |
| Q24239835 | Thrombolytic therapy for pulmonary embolism |
| Q24246260 | Thrombolytic therapy for pulmonary embolism |
| Q34714536 | Thrombolytic therapy for the treatment of acute pulmonary embolism |
| Q41292111 | Thrombolytic therapy for treatment of pulmonary embolism in the postoperative period: case report and review of the literature |
| Q68649428 | Thrombolytic therapy for venous thromboembolism |
| Q33636738 | Thrombolytic therapy for venous thrombosis and pulmonary embolism |
| Q35081866 | Thrombolytic therapy: clinical applications |
| Q36895343 | Thrombolytic treatment and new calcium antagonists |
| Q38739372 | Use of thrombolytic drugs in non-coronary disorders |
| Q39592542 | Venous thromboembolism: epidemiology, diagnosis, prevention |
| Q34109256 | Why thrombolytic therapy. |
| Q50951854 | [Evolution of pulmonary scintigraphy in the follow-up of pulmonary embolism. Effect of anticoagulant treatment and other associated factors] |
| Q69041681 | [Should pulmonary embolism be treated with thrombolytic agents?] |
| Q72993234 | [Treatment of venous thromboembolism] |
Search more.